Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS®) and its relationship to sociodemographic, clinical and psychopathological variables

Schizophrenia Research

Volumn 107, Issue 2-3, 2009, Pages 213-217

  Acosta, Francisco J ^a   Bosch, Esperanza ^a   Sarmiento, Gerardo ^a   Juanes, Nuria ^a   Caballero Hidalgo, Araceli ^b   Mayans, Teresa ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

Author keywords

Electronic monitoring; Insight; MEMS; Nonadherence; Noncompliance; Schizophrenia

Indexed keywords

MEDICATION EVENT MONITORING SYSTEM; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DEVICE; DRUG MONITORING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL TECHNOLOGY; MENTAL DISEASE; OUTPATIENT; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADULT; ANTIPSYCHOTIC AGENTS; DRUG PACKAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MEDICATION ADHERENCE; MICROCOMPUTERS; MIDDLE AGED; OBSERVER VARIATION; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 58249085188     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.09.007     Document Type: Article

References (36)

1. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., and Gorman J.M. Assessment of insight in psychosis. Am. J. Psychiatry 150 (1993) 873-879
2. Ascher-Svanum H., Zhu B., Faries D., Lacro J.P., and Dolder C.R. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J. Clin. Psychatry 67 (2006) 1114-1123
3. Byerly M., Fisher R., Whatley K., Holland R., Varghese R., Carmody T., Magouirk B., and Rush A.J. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 133 (2005) 129-133
4. Byerly M.J., Fisher R., Carmody T., and Rush A.J. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder. J. Clin. Psychiatry 66 (2005) 997-1001
5. Byerly M.J., Nakonezny P.A., and Lescouflair E. Antipsychotic medication adherence in schizophrenia. Psychiatr. Clin. North Am. 30 (2007) 437-452
6. Byerly M.J., Thompson A., Carmody T., Bugno R., Erwin T., Kashner M., and Rush A.J. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr. Serv. 58 (2007) 844-847
7. Cuffel B., Alford J., Fischer E.P., and Owen R. Awareness of illness in schizophrenia and outpatient treatment adherence. J. Nerv. Ment. Dis. 184 (1996) 653-659
8. Díaz E., Levine H.B., Sullivan M.C., Sernyak M.J., Hawkins K.A., Cramer J.A., and Woods S.W. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J. Psychiatry Neurosci. 26 (2001) 325-329
9. Díaz E., Neuse E., Sullivan M.C., Pearsall H.R., and Woods S.W. Adherence to conventional and atypical antipsychotics after hospital discharge. J. Clin. Psychiatry 65 (2004) 354-360
10. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin. Ther. 21 (1999) 1074-1090
11. Frangou S., Sachpazidis I., Stassinakis A., and Sakas G. Telemonitoring of medication adherence in patients with schizophrenia. Telemed. J. E. Health 11 (2005) 675-683
12. Gilmer T.P., Dolder D.R., Lacro J.P., Folsom D.P., Lindamer L., García P., and Jeste D.V. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am. J. Psychiatry 161 (2004) 692-699
13. Hawton K., Sutton L., Haw C., Sinclair J., and Deeks J. Schizophrenia and suicide: systematic review of risk factors. Br. J. Psychiatry 187 (2005) 9-20
14. Heyscue B.E., Levin G.M., and Merrick J.P. Compliance with depot antipsychotic medication by patients attending outpatient clinics. Psychiatr. Serv. 49 (1998) 1232-1234
15. Hui C., Chen E., Kan C.S., Yip K.C., Law C.W., and Chiu C. Detection of non-adherent behaviour in early psychosis. Aust. N. Z. J. Psychiatry 40 (2006) 446-451
16. Hui C., Chen E., Kan C.S., Yip K.C., Law C.W., and Chiu C. Anti-psychotics adherence among out-patients with schizophrenia in Hong Kong. Keio J. Med. 55 (2006) 9-14
17. Kane J.M. Compliance issues in outpatient treatment. J. Clin. Psychopharmacol. 5 Suppl. 3 (1985) 22-27
18. Kane J.M. Treatment adherence and long-term outcomes. CNS Spectr. 12 10 Suppl. 17 (2007) 21-26
19. Kay S., Fiszbein A., and Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 13 (1987) 261-276
20. Keith S.J., and Kane J.M. Partial compliance and patient consequences in schizophrenia: our patients can do better. J. Clin. Psychiatry 64 (2003) 1308-1315
21. Kikkert M.J., Schene A.H., Koeter M.W., Robson D., Born A., Helm H., Nose M., Goss C., Thornicroft G., and Gray R.J. Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. Schizophr. Bull. 32 (2006) 786-794
22. Kikkert M.J., Barbui C., Koeter M.W.J., David A.S., Leese M., Tansella M., Gießler A., Puschner B., and Schene A.H. Assessment of medication adherence in patients with schizophrenia. The Achilles Heel of adherence research. J. Nerv. Ment. Dis. 196 (2008) 274-281
23. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., and Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 63 (2002) 892-909
24. Landis R.J., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
25. Nakonezny P.A., and Byerly M.J. Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs. second-generation antipsychotics. Schizophr. Res. 82 (2006) 107-114
26. Nakonezny P., Byerly M., and Rush A.J. Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity. Psychiatry Res. 157 (2008) 259-263
27. Oehl M., Hummer W., and Fleischhacker W. Compliance with antipsychotic treatment. Acta Psychiatr. Scand. 407 (2000) 83-86 (Suppl.)
28. Remington G., Kwon J., Collins A., Laporte D., Mann S., and Christensen B. The use of electronic monitoring (MEMS®) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr. Res. 90 (2007) 229-237
29. Rittmannsberger H., Pachinger T., Keppelmüller P., and Wancata J. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr. Serv. 55 (2004) 174-179
30. Robinson D.G., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., and Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 56 (1999) 241-247
31. Robinson D.G., Woerner M.G., Alvir J.M., Bilder R.M., Hinrichsen G.A., and Lieberman J.A. Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophr. Res. 57 (2002) 209-219
32. Sharma T., and Antonova L. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr. Clin. North. Am. 26 (2003) 25-40
33. Tacchi M.J., and Scott J. The cost and consequences of inadequate treatment. In: Tacchi M.J., and Scott J. (Eds). Improving adherence in schizophrenia and bipolar disorders (2005), John Wiley & Sons, Chichester 9-15
34. Thieda P., Beard S., Richter A., and Kane J. An economic review of compliance with medication therapy in the treatment of schizophrenia. Psychiatr. Serv. 54 (2003) 508-516
35. Velligan D.I., Lam Y.W., Glahn D.C., Barret J.A., Maples N.J., Ereshefsky L., and Miller A.L. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr. Bull. 32 (2006) 724-742
36. Weiden P.J., and Olfson M. Cost of relapse in schizophrenia. Schizophr. Bull. 21 (1995) 419-429